Navigation Links
Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
Date:11/6/2007

iotensin II, which was dose-dependent and long-lived but reversible with a half-life of about 4 months. Also efficacy was dose-dependent and a significant reduction of the mean ambulatory day-time blood pressure was observed in the group who received the 300 mg dose of the vaccine. Systolic blood pressure (SBP) was reduced by 5.6 mmHg and diastolic blood pressure (DBP) by 2.8 mmHg from baseline.

Furthermore, strong efficacy of the vaccine was observed in the early morning hours, a critical time period when serious cardiovascular events occur frequently. The early morning rise of blood pressure starting at 5 am was significantly reduced by the vaccine, leading at 8 am to a blood pressure difference from baseline of (SBP / DBP) - 25 / - 13 mmHg compared to placebo.

Prof. Juerg Nussberger comments: "Despite the fact that effective drugs are available to treat hypertension, only about one out of four hypertensive patients has the blood pressure successfully controlled. Once people are aware of the often symptomless hypertension, they have to take their medications daily, and many are apparently unable or unwilling to take pills every day for the rest of their lives. The major remaining medical need in this important therapeutic area is thus improved patient compliance. If we could support or substitute the oral therapy with a vaccine that would need to be given just every few months, I think we could achieve a better control of high blood pressure."

Prof. Nussberger adds: "A particularly interesting finding of this study is the excellent control of the blood pressure in the early morning hours achieved by the vaccine. This is a crucial time period when serious events like myocardial infarction and stroke are more likely to occur than during other times of the day. Since currently available drugs often have too short half-lives to affect the rise in early morning blood pressure, this could become a major advantage of the novel vaccine approach. I am loo
'/>"/>

SOURCE Cytos Biotechnology AG
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Strategic Diagnostics Updates Roth Conference Presentation Time
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
4. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
5. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
9. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
10. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
11. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... the atrial fibrillation drug market will increase more ... $6.1 billion in 2018 in the United States, ... Japan. ,, The new Pharmacor report entitled ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
(Date:12/11/2009)... 11 Marrone Bio Innovations (MBI) today ... team. Mr. Chris Hildreth joined MBI as Senior ... for expanding all commercial aspects of the company, ... Kin Sing (Ray) Lam joined MBI as Vice ... development efforts in scaling its broad pipeline of ...
(Date:12/10/2009)... Microban International, Ltd., the global leader in ... Sharp Imaging and Information Company of America, ... it,s third generation silver-based antimicrobial technology into ... calculator keys during manufacture, Microban ® ... bacteria on the keys. ,, This ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2
... Incident Report Solution Expedites Reporting Process, WALL, ... Board: BKYI), a leader in wireless public safety,solutions ... award for $96,000 from the Littleton, Colorado Police ... incident reporting system,which is a module of BIO-key,s ...
... - Continued Strong Organic Growth, With Revenue Up 8.5% Like-for-Like Essilor International, the world leader ... revenue for the first nine months, EUR millions ... % change Like-for-like ... months) ...
... Center for Applied Nanoionics (CANi) has a new take on ... and battery life of consumer electronics from digital cameras to ... materials and compatible with just about anything currently on the ... a way for this memory to be made at essentially ...
Other Biology Technology:BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department 2Essilor's 2007 Third-Quarter Report 2Essilor's 2007 Third-Quarter Report 3Essilor's 2007 Third-Quarter Report 4ASU researchers improve memory devices using nanotech 2ASU researchers improve memory devices using nanotech 3
(Date:12/14/2009)... spending the holidays with big Uncle Frank or bossy ... off with another family, spare a thought for the ... McMaster University and the University of New South Wales ... in groups, members make strategic decisions about their living ... issue of Biology Letters . , The helper ...
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... New Haven, Conn.A team led by Yale University ... in whole blood for the first time. Their ... online publication of Nature Nanotechnology , could ... of cancer and other diseases. , ... Professor of Engineering & Applied Science, and Tarek ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Scientists use nanosensors for first time to measure cancer biomarkers in blood 2This idea doesnt stink 3A New tech cuts industrial odors pollutants 9701 1This idea doesnt stink 3A New tech cuts industrial odors pollutants 9701 2Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 1Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 2Solta Medical Launches New Fraxel re 3Astore 28R 29 Dual Laser System 55402 3Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 1Hill Rom to Participate at the Thomas Weisel Partners 2009 Healthcare Conference 55399 2
... Institutes Baumann Lab has identified the long-sought telomerase RNA ... been posted to the Web site of the journal ... a future print edition. , Chromosomes shorten with ... cells, this shortening is compensated by telomerase, an enzyme ...
... 2007 Five young Hebrew University of Jerusalem ... the European Unions first competition for outstanding starting ... Hebrew University winners totals 6,380,000 euros. ... of having presented excellent, ground-breaking research ideas, plus ...
... in a protein called dynein, required for the proper functioning ... may provide crucial clues leading to better treatments for a ... three percent of all those over age 60. , ... processes that are located outside the brain and spinal cord. ...
Other Biology News:Baumann lab identifies elusive telomere RNA subunit in single cell model 2Five young Hebrew University scientists win first competitive EU grants 2Mutation may cause inherited neuropathy 2Mutation may cause inherited neuropathy 3
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
... versatile enclosures are designed ... or other process gas ... environment. HEPA filtration, heating/cooling, ... modules also available, along ...
... modular cleanroom for biological safety labs ... cleanliness (to Class 10/ISO 3) and ... create ultra-smooth surfaces that are easy ... radius corners simplify cleaning. Unique double-wall ...
Biology Products: